COVID-19 susceptibility causally related to stroke risk: Using SARS-CoV-2 infection as a natural test of disease predisposition?

2024-9-1

Can the outlier percentiles from norms increase the sensitivity of the ECG criteria for screening athletes?

2024-9-1

Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions

2024-9-1

Substances use and risk of hypertension before midlife in military young adults: Chief cohort study, 2014–2020

2024-8-1

Reflections on community experience with Mavacamten

2024-8-1

Advancements and future perspectives in coronary angiography-derived fractional flow reserve

2024-8-1

The prevalence, patients' characteristics, and hyper-Lp(a)-emia risk factors in the polish population. The first results from the PMMHRI-Lp(a) registry

2024-8-1

Testosterone replacement therapy and cardiovascular risk: TRAVERSE with caution

2024-7-1

Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials

2024-7-1

Comparing the efficacy and safety of endovascular therapy versus surgical revascularization for critical limb-threatening ischemia: A systematic review and meta-analysis

2024-7-1

Antegrade techniques for chronic total occlusion percutaneous coronary intervention

2024-7-1

List of recent issues

2024-7-1

Table of contents

2024-7-1

Editorial Board

2024-7-1

Anthracyclines, diastolic dysfunction and the road to heart failure in Cancer survivors: An untold story

2024-7-1

Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment

2024-7-1

Introduction to assorted topics 2024

2024-7-1

Cardiovascular statistics 2024

2024-7-1

Cover 2 (Masthead)

2024-7-1

Dose-response associations of the American Heart Association's new “Life's essential 8” metrics with all-cause and cardiovascular mortality in a nationally representative sample from the United States

2024-6-1

Stratified medicine for acute and chronic coronary syndromes: A patient-tailored approach

2024-6-1

Calcified coronary lesions: Imaging, prognosis, preparation and treatment state of the art review

2024-6-1

Normative values for body composition in 22,191 healthy Norwegian adults 20–99 years: The HUNT4 study

2024-6-1

The premise, promise, and perils of artificial intelligence in critical care cardiology

2024-6-1

The ethnic and racial diversity of patients undergoing coronary artery calcium scanning

2024-6-1

The role of artificial intelligence in cardiovascular magnetic resonance imaging

2024-6-1

Pathophysiology, diagnosis and management of right ventricular failure: A state of the art review of mechanical support devices

2024-6-1

Understanding the spectrum of cardiovascular risk in women - A primer for prevention

2024-5-1

Inequities in atherosclerotic cardiovascular disease prevention

2024-5-1

Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use

2024-5-1

Preventive medicine and cardiac CT- Their move into mainstream medicine

2024-5-1

Table of contents

2024-5-1

The utility of coronary artery calcium scoring to enhance cardiovascular risk assessment for South Asian adults

2024-5-1

Predictors of short-term and long-term effects of mavacamten in obstructive hypertrophic cardiomyopathy

2024-5-1

List of recent issues

2024-5-1

All we need to know about lipoprotein(a)

2024-5-1

Innovations in cardiac computed tomography: Imaging in coronary artery disease

2024-5-1

Cover 2 (Masthead)

2024-5-1

Editorial Board

2024-5-1

A meta-analysis of direct oral anticoagulants vs warfarin for left ventricular thrombus

2024-3-27

Comparison of risk profiles of participants in the Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD (WARRIOR) trial, using Coronary Computed Tomography Angiography vs Invasive Coronary Angiography

2024-3-26

Excess mortality for acute myocardial infarction in the United States during the first two years of the COVID-19 pandemic

2024-3-20

Developing effective strategies to optimize physical activity and cardiorespiratory fitness in the long Covid population- The need for caution and objective assessment

2024-3-1

Assessing cardiorespiratory fitness in clinical and community settings: Lessons and advancements in the 100th year anniversary of VO2max

2024-3-1

Artificial intelligence in preventive cardiology

2024-3-1

Cardiorespiratory fitness and physical activity in the lens of social justice – Reporting on the disparities that exist

2024-3-1

Qualitative systems mapping in promoting physical activity and cardiorespiratory fitness: Perspectives and recommendations

2024-3-1

The current state of physical activity assessment and interventions with public policy solutions

2024-3-1

Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases

2024-3-1

Editorial Board

2024-3-1